This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate ...
Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward Treating ...
Efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab [TCH-P] in non-metastatic HER2+ breast cancer: The Cleveland Clinic experience. This ...
Though it has long been recognized that the liver exhibits remarkable immune tolerance, the underlying mechanisms driving ...
Abstract: Variation in endocrine pathways can be a major mechanism underlying life‐history evolution. Yet it is unclear whether this insight, derived primarily from solitary species, explains the ...
In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...
A team of scientists at the Garvan Institute of Medical Research has discovered that inactivation of a stress pathway makes ER+ breast cancer cells ignore stress signals, allowing them to evade ...
Growing concerns about environmental contaminants associated with adverse developmental, reproductive, neurological, and immune effects led Congress more than 20 years ago to direct the U.S.